Page 18 - Company Or Core News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD62, WKN: A2P8K3) (the “ Company” or “ Core One”) is pleased to announce it has appointed Dr. Santiago Ferro, Chief Executive Officer of Akome Biotech Ltd. (“ Akome”), as Chief Medical Officer of the Company. Dr. Ferro will lead the Company through clinical trials and commercialization of its psychedelic products. Dr. Ferro is a graduate of Javeriana University Medical School in his native Bogotá, Colombia, where he specialized in Internal Medicine, and received his sub-specialty training in Infectious Diseases at University of Toronto. Following completion of his medical and specialty training, Dr. Ferro returned to Bogotá and established a private practice in both Internal Medicine and Infectious Diseases, while at the same time held academic positions at different teaching hospitals.

United statesUnited kingdomNew jerseyBritish columbiaSanofi pasteurSmith kleinJoel shackerJaveriana university medical schoolClinical team leaderColombian infectious disease societyCore one labs incInfectious disease expert at novartis pharmaceuticalsAkome biotech ltdMalaria vaccine initiative in bethesdaHealth canadaInfectious diseases at university of toronto